Application
IHC-P analysis of human colon carcinoma using CTAG2 antibody at a dilution of 1:200.Application
WB analysis of mouse intestine (lane 1) and mouse testis (lane 2) lysates using GRM1 antibody at a dilution of 1:200.Application
IHC-P analysis of human gastric carcinoma using CTAG2 antibody at a dilution of 1:200.| Product Name | CTAG2 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to CTAG2This gene encodes an autoimmunogenic tumor antigen that belongs to the ESO/LAGE family of cancer-testis antigens. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. This protein is also expressed in normal testis tissue. An alternative open reading frame product of this gene has been described in PMID 10399963. This alternate protein, termed CAMEL, is a tumor antigen that is recognized by melanoma-specific cytotoxic T-lymphocytes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010] |
| Immunogen | The immunogen corresponding to a region within amino acids 140 and 190 of human CTAG2. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| Recommended Starting Dilutions: For WB: Use at a dilution of 1:100-1:1000. For IHC-P: Use at a dilution of 1:100 - 1:500. Optimal dilutions should be determined experimentally by the researcher. | |
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | CT6.2b, CT6.2a, LAGE2B, LAGE-1, ESO2, cancer/testis antigen 2, CT2, CT6.2, CAMEL |
|---|---|
| Target | CTAG2 |
| Tissue Specificity | CTAG2 |
Application
IHC-P analysis of human colon carcinoma using CTAG2 antibody at a dilution of 1:200.
Application
WB analysis of mouse intestine (lane 1) and mouse testis (lane 2) lysates using GRM1 antibody at a dilution of 1:200.
Application
IHC-P analysis of human gastric carcinoma using CTAG2 antibody at a dilution of 1:200.| Application Notes | Recommended Starting Dilutions: For WB: Use at a dilution of 1:100-1:1000. For IHC-P: Use at a dilution of 1:100 - 1:500. Optimal dilutions should be determined experimentally by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Aqueous buffered solution containing 100ug/ml BSA, 50% glycerol and less than 0.09% sodium azide. |
